Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Niagen Bioscience (NAGE) over the last 15 years, with Q3 2025 value amounting to $86.6 million.

  • Niagen Bioscience's Shares Outstanding (Diluted Average) rose 1138.13% to $86.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $86.6 million, marking a year-over-year increase of 1138.13%. This contributed to the annual value of $78.1 million for FY2024, which is 418.75% up from last year.
  • Latest data reveals that Niagen Bioscience reported Shares Outstanding (Diluted Average) of $86.6 million as of Q3 2025, which was up 1138.13% from $86.2 million recorded in Q2 2025.
  • In the past 5 years, Niagen Bioscience's Shares Outstanding (Diluted Average) ranged from a high of $86.6 million in Q3 2025 and a low of $64.2 million during Q1 2021
  • For the 5-year period, Niagen Bioscience's Shares Outstanding (Diluted Average) averaged around $73.9 million, with its median value being $75.0 million (2023).
  • As far as peak fluctuations go, Niagen Bioscience's Shares Outstanding (Diluted Average) grew by 15.97% in 2022, and later skyrocketed by 1413.73% in 2025.
  • Quarter analysis of 5 years shows Niagen Bioscience's Shares Outstanding (Diluted Average) stood at $67.2 million in 2021, then increased by 3.79% to $69.7 million in 2022, then rose by 7.54% to $75.0 million in 2023, then increased by 4.19% to $78.1 million in 2024, then rose by 10.87% to $86.6 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $86.6 million in Q3 2025, compared to $86.2 million in Q2 2025 and $83.2 million in Q1 2025.